AR054381A1 - Metodo de lberacion controlada de una droga a traves de la piel - Google Patents

Metodo de lberacion controlada de una droga a traves de la piel

Info

Publication number
AR054381A1
AR054381A1 ARP060102384A ARP060102384A AR054381A1 AR 054381 A1 AR054381 A1 AR 054381A1 AR P060102384 A ARP060102384 A AR P060102384A AR P060102384 A ARP060102384 A AR P060102384A AR 054381 A1 AR054381 A1 AR 054381A1
Authority
AR
Argentina
Prior art keywords
drug
skin
solubilized
vitamin
film
Prior art date
Application number
ARP060102384A
Other languages
English (en)
Spanish (es)
Inventor
Philippe Andres
Claire Mallard
Original Assignee
Galderma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Sa filed Critical Galderma Sa
Publication of AR054381A1 publication Critical patent/AR054381A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ARP060102384A 2005-06-10 2006-06-08 Metodo de lberacion controlada de una droga a traves de la piel AR054381A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US68928205P 2005-06-10 2005-06-10

Publications (1)

Publication Number Publication Date
AR054381A1 true AR054381A1 (es) 2007-06-20

Family

ID=37137556

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP060102384A AR054381A1 (es) 2005-06-10 2006-06-08 Metodo de lberacion controlada de una droga a traves de la piel

Country Status (11)

Country Link
EP (1) EP1901709A2 (ja)
JP (1) JP2008542423A (ja)
KR (1) KR20080016612A (ja)
CN (1) CN101247787B (ja)
AR (1) AR054381A1 (ja)
AU (1) AU2006256860B2 (ja)
BR (1) BRPI0613230A2 (ja)
CA (1) CA2610755A1 (ja)
MX (1) MX2007015672A (ja)
RU (1) RU2008100037A (ja)
WO (1) WO2006131401A2 (ja)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2909284B1 (fr) * 2006-11-30 2012-09-21 Galderma Sa Nouvelles compositions sous forme d'onguent sans vaseline comprenant un derive de vitamine d et eventuellement un anti-inflammatoire steroidien
CN103480026A (zh) * 2007-03-08 2014-01-01 莫科治疗有限公司 一种疤痕敷料制剂
JP2010533186A (ja) * 2007-07-11 2010-10-21 ダウ・コーニング・コーポレイション 薬物を送達するための組成物
MX2012000434A (es) * 2009-07-09 2012-04-11 Crescendo Therapeutics Llc Metodo de sanacion de herida y modulacion de cicatriz.
US9254296B2 (en) 2009-12-22 2016-02-09 Leo Pharma A/S Pharmaceutical composition comprising vitamin D analogue and cosolvent-surfactant mixture
NZ601002A (en) * 2009-12-22 2014-09-26 Leo Pharma As Pharmaceutical composition comprising vitamin d analogue and cosolvent-surfactant mixture
US20160095876A1 (en) 2014-10-01 2016-04-07 Rochal Industries, Llp Composition and kits for inhibition of pathogenic microbial infection and methods of using the same
TW201636025A (zh) * 2015-04-15 2016-10-16 Maruho Kk 皮膚用之醫藥組成物
KR20190026397A (ko) 2017-09-05 2019-03-13 안준배 노이즈 필터링 장치 및 방법

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5122519A (en) * 1989-06-27 1992-06-16 American Cyanamid Company Stable, cosmetically acceptable topical gel formulation and method of treatment for acne
JPH03275619A (ja) * 1990-03-23 1991-12-06 Nitsusui Seiyaku Kk 外用剤組成物
JP3251717B2 (ja) * 1992-06-29 2002-01-28 花王株式会社 皮膚外用剤
JP3573803B2 (ja) * 1994-02-16 2004-10-06 ポーラ化成工業株式会社 皮膚外用剤
CA2248977A1 (en) * 1996-03-16 1997-09-25 Hoechst Aktiengesellschaft Topical formulations for the treatment of nail psoriasis
GB9902812D0 (en) * 1998-06-18 1999-03-31 Dow Corning Sa Composition for delivering pharmaceutically active agents
US6200964B1 (en) * 1999-05-28 2001-03-13 Neutrogena Corporation Silicone gel containing salicylic acid
WO2000072817A1 (en) * 1999-05-28 2000-12-07 Neutrogena Corporation Water-in-oil emulsion comprising a silicone gel containing vitamin c
US6365670B1 (en) * 2000-03-10 2002-04-02 Wacker Silicones Corporation Organopolysiloxane gels for use in cosmetics
DE10019128A1 (de) * 2000-04-18 2001-11-15 Wella Ag Aerosolschaum zur Haarbehandlung
US6410038B1 (en) * 2000-06-14 2002-06-25 Dow Corning Corporation Water-in-oil-in-polar solvent emulsions
ES2298264T3 (es) * 2000-10-27 2008-05-16 Leo Pharma A/S Composicion topica que contiene al menos una vitamina d o un analogo de vitamina d y al menos un corticoesteroide.
JP2004189639A (ja) * 2002-12-09 2004-07-08 Pola Chem Ind Inc 乳化組成物
US20040228821A1 (en) * 2003-05-16 2004-11-18 The Procter & Gamble Company Personal care products comprising active agents in a gel network
ATE388697T1 (de) * 2003-11-21 2008-03-15 Galderma Res & Dev Sprühbare zusammensetzung zur verabreichung von vitamin d derivaten
FR2871697B1 (fr) * 2004-06-17 2007-06-29 Galderma Sa Composition sous forme de spray comprenant une association d'actifs pharmaceutiques, une phase alcoolique, au moins un silicone volatile et une phase huileuse non volatile

Also Published As

Publication number Publication date
KR20080016612A (ko) 2008-02-21
AU2006256860A1 (en) 2006-12-14
MX2007015672A (es) 2008-02-20
BRPI0613230A2 (pt) 2011-01-04
RU2008100037A (ru) 2009-07-20
WO2006131401A3 (en) 2007-03-15
CN101247787A (zh) 2008-08-20
CA2610755A1 (en) 2006-12-14
WO2006131401A2 (en) 2006-12-14
JP2008542423A (ja) 2008-11-27
CN101247787B (zh) 2011-10-05
EP1901709A2 (en) 2008-03-26
AU2006256860B2 (en) 2012-04-19

Similar Documents

Publication Publication Date Title
AR054381A1 (es) Metodo de lberacion controlada de una droga a traves de la piel
CR9351A (es) Composiciones y metodos para aplicaicon topica y suministro transdermico de toxina botulinica
BR112015022223A2 (pt) composições tópicas e métodos de tratamento de distúrbios tópicos
NI201000193A (es) Formulaciones orales de análogos de citidina y métodos de uso de las mismas.
AR050717A1 (es) Composiciones farmaceuticas
AR049518A1 (es) Composicion farmaceutica que comprende un agente siliconado y dos principios activos solubilizados
CO6311008A2 (es) Composicion farmaceutica que comprende un agente que activa las celulas t regulatorias cd4+cd25+
BRPI0516830A (pt) composições de droga de liberação sustentada convenientemente implantáveis
UY30442A1 (es) Composiciones farmaccuticas de ropinirol, mctodos de uso, proceso de preparacinn y aplicaciones.
AR047799A1 (es) Capsula de gelatina blanda que contiene una formulacion farmaceutica con al menos un acido graso poli-insaturado omega-3
BR112014010645A2 (pt) composições perfumantes e usos das mesmas
ECSP066715A (ja)
CL2011000144A1 (es) Compuestos derivados de benzo (1,4) dioxin-2-ilmetil-sulfamida; composiciones farmaceuticas que los contienen; proceso para prepararlos y uso en el tratamiento de la ansiedad, epilepsia, dolor, abuso de sustancias, trastornos relacionados, entre otros.
CO2019005729A2 (es) Preparación de complejos sólidos de ciclodextrina para suministro de ingredientes farmacéuticos activos oftálmicos
BRPI0519070A2 (pt) composiÇço de fator de crescimento de queratinàcito liofilizada, mÉtodos para preparar um fator de crescimento de queratinàcito liofilizado, e para tratar uma doenÇa, e, kit para preparar uma composiÇço farmacÊutica aquosa
BR112015020049A8 (pt) composição na forma de uma emulsão óleo-em-água e processos cosméticos
ATE492271T1 (de) Verfahren zur herstellung eines hydroxystilben- haltigen drogenextraktes
AR046642A1 (es) Composicion en forma de spray que comprende un activo farmaceutico, al menos una silicona volatil y una fase aceitosa, no volatil
AR077372A1 (es) Composiciones y metodos para tratar infecciones oftalmicas oticas o nasales
AR055591A1 (es) Una composicion topica protectora de la piel y su uso
ATE284698T1 (de) Aktivierung natürlicher killerzellen durch adenosin-a3-rezeptoragonisten
BRPI0606373A2 (pt) composição de xarope compreendendo dexibuprofeno como ingrediente ativo e método para a preparação da mesma
DOP2009000262A (es) Una composicion de liberacion prolongada que comprende un derivado de somatostatina en microparticulas
CL2008003231A1 (es) Compuestos derivados de 1,3-dihidro-5-isobenzofurancarbonitrilo sustituido, inhibidores selectivos de la recaptacion de serotonina; composicion farmaceutica; procedimiento de preparacion; utiles en el tratamiento y/o prevencion de la eyaculacion prematura.
CO6280474A2 (es) Composicion farmaceutica para el tratamiento de la eyaculacion precoz

Legal Events

Date Code Title Description
FB Suspension of granting procedure